Member Info for Hurst10

AVA3396 news and the US are very keen on the Precision medicine, with all the majors fresh from JP Morgan conference.

From today’s RNS, an important and interesting comment from Alastair Smith is that he mentions the pre-CISION platform has not only the potential to improve the safety and tolerability of chemotherapies but also other drugs!This is first time he has mentioned the potential for other drugs.This would of course widen the potential of the pre-CISION platform.
:
“We're delighted with the very positive data emerging from the dose escalation study of our lead pre|CISION(TM) tumour targeted therapy AVA6000. The very significant reduction in the usual toxicities, plus the observed release of doxorubicin at significant levels in the tumour tissue, show that the pre|CISION(TM) platform has the potential to significantly improve the safety and tolerability of chemotherapies, and other drugs, by targeting their release to the tumour.”

Size buying
Above 160
Good morning NY

Size buyer will start again, 170-5 by 05.00 AM NY time.
However once everyone incl. US understands how big this is and what kind of upfront license payments the majors will offer and then put a value on AVA3396 followed by the rest of the AVA family, current share price is ridiculously low!

Think you will find, that US based U.K. equity investment managers, does not have US bank holidays.
Watch the price, Market makers will front run orders coming in!

Market have got “ working order” from the US.
Very normal!

10/ size buyer back in town, market will be bidding 140 shortly.

Unless you were certain about the future, this would not be done!
New 52 week high before the close
U.K. investors based in NY will have a busy morning.

Size order??

AVA3396 in negotiations
Meanwhile we have AVA6000
LG chem
In talks
Have a good week end
H

Monday post RNS , “ size orders”
Marvellous !

Suspect a RNS will carry a confirmation of a license deal being put together.

Now size buyer at 134.10

Wish everybody a good week end, interesting Monday and week awaits!
Almost 17.00hrs a glass or two of Burgundy awaits, while playing Avacta’s national anthem “ Lifted” by Lighthouse family.

Still awaiting post hours size prints!
134.10 print for 135 shares so far
Enjoy the week end
Sure Avacta will
Not long before AS will ring the bell on the floor!

Remember AS in previous company video presentation, confirmed that upon confirmation AVA6000 RNS, license talks with a major would commence.

Sometime before the end of March, a person with the inherited blood disease beta thalassemia will receive an infusion containing hundreds of millions of their own stem cells. These cells will have just completed a round-trip journey to a drug manufacturing facility, where they'll be equipped with a modified gene capable of fixing the patient's condition.

The expected infusion will be the first commercial use of a gene therapy approved by the Food and Drug Administration in August.
This is off course hugely relevant for Avacta and the value of it’s holding in Affyxel and events last year:

AffyXell, Avacta’s joint venture with Daewoong Pharmaceutical, expands its manufacturing partnership with GenScript ProBio for cell therapies
GenScript ProBio agrees to take an equity stake in AffyXell as a strategic investor at next funding round

Last chance to get stock below 140.
BEGO will clean up and there will be no sellers after 15.00
I maintain 140-4 closing

Nice price move before lunch time, size buyers from NY will push it through 140.
Usual bidder will be back.

Size buyer pre and post closure!